BETA

Beta Drugs Share Price Beta Drugs

₹1,233.75
2.1 (0.17%)
29 March, 2024 02:16 BSE: 531481 NSE: BETAISIN: INE351Y01019

Start SIP in Beta Drugs

Start SIP

Beta Drugs Performance

Day Range

  • Low 1,197
  • High 1,263
₹ 1,233

52 Week Range

  • Low 607
  • High 1,595
₹ 1,233
  • Open Price1,250
  • Previous Close1,232
  • Volume3200

Beta Drugs Share Price

  • Over 1 Month -2.2%
  • Over 3 Month -17.24%
  • Over 6 Month 23.38%
  • Over 1 Year 101.58%

Beta Drugs Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 1,186
Price to Book Ratio 9.7
EPS 19.6
Dividend 0
Relative Strength Index 48.24
Money Flow Index 44.19
MACD Signal -27.36
Average True Range 68.86
Beta Drugs Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr 159
Operating Expenses Annual Cr 127
Operating Profit Annual in Cr 31
Depreciation Cr 6
Interest Annual Cr 1
Tax Annual Cr 6
Net Profit Annual Cr 19
IndicatorMar 2023
Cash from Operating Activity Annual Cr 10
Cash from Investing Activity Annual Cr -6
Cash from Financing Annual Activity Cr -2
Net Cash Flow Annual Cr 2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 96
Fixed Assets Annual Cr 35
Total Non Current Assets Annual Cr 49
Total Current Assets Annual Cr 85
Total Assets Annual Cr 134
IndicatorMar 2023
Book Value Per Share Annual Rs 100
ROE Annual % 20
ROCE Annual % 25
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 20
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr 228
Operating Expenses Annual Cr 174
Operating Profit Annual in Cr 53
Depreciation Cr 10
Interest Annual Cr 2
Tax Annual Cr 10
Net Profit Annual Cr 31
IndicatorMar 2023
Cash from Operating Activity Annual Cr 23
Cash from Investing Activity Annual Cr -19
Cash from Financing Annual Activity Cr -2
Net Cash Flow Annual Cr 2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 123
Fixed Assets Annual Cr 63
Total Non Current Assets Annual Cr 71
Total Current Assets Annual Cr 128
Total Assets Annual Cr 198
IndicatorMar 2023
Book Value Per Share Annual Rs 128
ROE Annual % 25
ROCE Annual % 32
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24

Beta Drugs Technicals

EMA & SMA

Current Price
₹1,233.75
2.1 (0.17%)
pointer
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • ₹1,237.18
  • 50 Day
  • ₹1,273.86
  • 100 Day
  • ₹1,248.76
  • 200 Day
  • ₹1,136.30
  • 20 Day
  • ₹1,218.62
  • 50 Day
  • ₹1,306.84
  • 100 Day
  • ₹1,309.84
  • 200 Day
  • ₹1,101.57

Beta Drugs Resistance and Support

PIVOT
₹1,231.34
Resistance
First Resistance 1,265.42
Second Resistance 1,297.08
Third Resistance 1,331.17
RSI 48.24
MFI 44.19
MACD Single Line -27.36
MACD -18.34
Support
First Resistance 1,199.67
Second Resistance 1,165.58
Third Resistance 1,133.92

Beta Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,200 230,016 71.88
Week 2,175 164,996 75.86
1 Month 4,638 331,902 71.56
6 Month 4,897 364,857 74.51

Beta Drugs Result Highlights

Beta Drugs Synopsis

NSE-Medical-Diversified

Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 157.87 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2023. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
Market Cap 1,186
Sales 158
Shares in Float 0.32
No of funds 2
Yield
Book Value 12.61
U/D Vol ratio 0.6
LTDebt / Equity 4
Alpha 0.15
Beta 1.25

Beta Drugs

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 66.73%66.73%66.73%66.73%
Foreign Portfolio Investors 0.32%0.32%0.29%0.29%
Individual Investors 22.33%22.37%22.24%22.52%
Others 10.62%10.58%10.74%10.46%

Beta Drugs Management

Name Designation
Mr. Rahul Batra Chairperson & Managing Director
Mr. Varun Batra Joint Managing Director
Mr. Balwant Singh Whole Time Director
Mrs. Seema Chopra Whole Time Director
Mr. Ashutosh Shukla Whole Time Director
Mr. Rohit Parti Independent Director
Mr. Manmohan Khanna Independent Director

Beta Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Beta Drugs Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results & Others To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE.
2023-05-08 Audited Results
2022-10-27 Quarterly Results
2022-04-27 Audited Results
2021-10-25 Quarterly Results

Beta Drugs MF Shareholding

Name Amount(cr)

Beta Drugs FAQs

What is Share Price of Beta Drugs ?

Beta Drugs share price is ₹1,233 As on 29 March, 2024 | 02:03

What is the Market Cap of Beta Drugs ?

The Market Cap of Beta Drugs is ₹1186.1 Cr As on 29 March, 2024 | 02:03

What is the P/E ratio of Beta Drugs ?

The P/E ratio of Beta Drugs is As on 29 March, 2024 | 02:03

What is the PB ratio of Beta Drugs ?

The PB ratio of Beta Drugs is 9.7 As on 29 March, 2024 | 02:03

Q2FY23